- Home
- ENLC vs ACLX Comparison
ENLC vs ACLX Comparison
Compare ENLC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLC
- ACLX
- Stock Information
- Founded
- ENLC 2013
- ACLX 2015
- Country
- ENLC United States
- ACLX United States
- Employees
- ENLC N/A
- ACLX N/A
- Industry
- ENLC Natural Gas Distribution
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- ENLC Utilities
- ACLX Health Care
- Exchange
- ENLC Nasdaq
- ACLX Nasdaq
- Market Cap
- ENLC 6.4B
- ACLX 5.3B
- IPO Year
- ENLC N/A
- ACLX 2022
- Fundamental
- Price
- ENLC $15.34
- ACLX $66.48
- Analyst Decision
- ENLC Hold
- ACLX Strong Buy
- Analyst Count
- ENLC 11
- ACLX 14
- Target Price
- ENLC $15.40
- ACLX $107.67
- AVG Volume (30 Days)
- ENLC 2.5M
- ACLX 695.1K
- Earning Date
- ENLC 02-18-2025
- ACLX 02-26-2025
- Dividend Yield
- ENLC 3.47%
- ACLX N/A
- EPS Growth
- ENLC N/A
- ACLX N/A
- EPS
- ENLC 0.22
- ACLX N/A
- Revenue
- ENLC $6,652,200,000.00
- ACLX $155,818,000.00
- Revenue This Year
- ENLC $1.51
- ACLX $12.58
- Revenue Next Year
- ENLC $14.54
- ACLX N/A
- P/E Ratio
- ENLC $69.53
- ACLX N/A
- Revenue Growth
- ENLC N/A
- ACLX 230.33
- 52 Week Low
- ENLC $11.53
- ACLX $47.88
- 52 Week High
- ENLC $16.40
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- ENLC 64.82
- ACLX 32.63
- Support Level
- ENLC $14.14
- ACLX $63.63
- Resistance Level
- ENLC $14.62
- ACLX $68.24
- Average True Range (ATR)
- ENLC 0.29
- ACLX 3.71
- MACD
- ENLC 0.15
- ACLX -0.69
- Stochastic Oscillator
- ENLC 90.10
- ACLX 16.43
About ENLC EnLink Midstream LLC Common Units representing Limited Partner Interests
EnLink Midstream LLC is an integrated midstream company. The company's operating segment includes Permian; North Texas; Oklahoma; Louisiana and Corporate. The company generates maximum revenue from the Louisiana segment. The Louisiana segment includes natural gas pipelines, natural gas processing plants, storage facilities, fractionation facilities, and NGL assets.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.